Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

BOSTON and LAUSANNE, Switzerland, January 10, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief BioPharma Officer and Abhimanyu (Abhi) Verma as Chief Technology Officer. The additions are part of SOPHiA GENETICS’ …

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business Read More »

SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference

BOSTON (MA), United States and LAUSANNE, Switzerland, Dec 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference. The virtual presentation will begin at 8:15 a.m. ET/2:15 p.m. CET on Tuesday, January …

SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference Read More »

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences: Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11th at 2:40pm ET / 8:40pm CET Piper Sandler 33rd Annual Healthcare Conference; Presentation available on demand beginning …

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences Read More »

transmutex - 4seeventures

Happy New Year

Best wishes of a joyful New Year to all. Let’s innovate and appreciate our common humanity.   READ MORE

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma companies CHICAGO, November 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and …

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Read More »

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance

Third quarter year-over-year revenue growth of 45%; executed Master Alliance Agreement with GE Healthcare BOSTON and LAUSANNE, Switzerland, November 10, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent Highlights Revenue was $10.4 million for the third quarter, representing a 45% increase over the corresponding …

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance Read More »